NCT04636138View on ClinicalTrials.gov

Pharmacogenomic Modulators of Impaired Exercise Adaptation in Statin Users

NAActive, not recruitingINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

June 3, 2021

Primary Completion Date

July 30, 2023

Study Completion Date

July 30, 2025

Conditions
HMG-CoA Reductase Inhibitor Toxicity
Interventions
OTHER

Exercise

Patients will exercise on a treadmill three times weekly at approximately 60% VO2max for 30 minutes (week one) followed by 45 minutes (week two and thereafter) for a total of 6 seeks.

Trial Locations (1)

66160

University of Kansas Medical Center, Kansas City

All Listed Sponsors
lead

University of Kansas Medical Center

OTHER